Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

[14C]HRS-9057

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · PHASE 1 TRIAL

A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants

ClinicalTrials.gov

Phase 1 open-label mass balance study in a small healthy cohort (n=6) designed to characterize drug disposition, not efficacy or safety, with no results yet reported in this registry record.

PreliminaryNCT07681479 Fluid Retention Due to Heart Failure [14C]HRS-9057

Reported

Planned enrollment6

Study phasePhase 1

Primary outcome measure 1Total radioactivity recovery and cumulative…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support